In response to increased sterile compounding oversight, Sarasota Memorial Health System utilized Simplifi 797 to comply with USP 797, ensuring patient safety. The industry continues to raise the bar on compliance with USP 797 — the accepted minimum practice standard—following a string of high-profile incidents that resulted in preventable patient harm.
In truth, USP 797 clean room guidelines and standards are far-reaching, requiring a high level of competency and oversight. In terms of achieving full compliance with the standard, SMH is part of only 41 percent of U.S. hospitals meeting or exceeding the goal, according to the 2024 edition of the annual State of Pharmacy Compounding.
As part of its greater patient safety and quality strategy, Sarasota Memorial has chosen to leverage Simplifi 797, a comprehensive quality management system, to elevate sterile compounding practices and comply with USP 797. “Sterile compounding processes are a critical component of patient care as well as a top patient safety concern. It’s very important that we achieve this higher standard of practice across all of our operations to avoid adverse patient events and provide the best care for our patients,” Sandra Prenosil, Manager, Pharmacy Services.
Download the case study to find out how Simplifi 797 helped Sarasota Memorial:
- Optimize the sterile compounding process
- Identify and mitigate compliance risks
- Standardize around a higher standard of practice
